China · Delayed Price · Currency is CNY Newland Pharmaceutical Statistics
Total Valuation
SHE:301277 has a market cap or net worth of CNY 5.00 billion. The enterprise value is 4.29 billion.
| Market Cap | 5.00B |
| Enterprise Value | 4.29B |
Important Dates
The next estimated earnings date is Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | Apr 16, 2025 |
Share Statistics
SHE:301277 has 392.08 million shares outstanding. The number of shares has increased by 0.39% in one year.
| Current Share Class | 392.08M |
| Shares Outstanding | 392.08M |
| Shares Change (YoY) | +0.39% |
| Shares Change (QoQ) | +2.96% |
| Owned by Insiders (%) | 63.76% |
| Owned by Institutions (%) | 0.72% |
| Float | 98.88M |
Valuation Ratios
The trailing PE ratio is 40.40.
| PE Ratio | 40.40 |
| Forward PE | n/a |
| PS Ratio | 7.46 |
| PB Ratio | 3.28 |
| P/TBV Ratio | 3.40 |
| P/FCF Ratio | 303.02 |
| P/OCF Ratio | 36.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.49, with an EV/FCF ratio of 260.01.
| EV / Earnings | 34.67 |
| EV / Sales | 6.40 |
| EV / EBITDA | 25.49 |
| EV / EBIT | 34.03 |
| EV / FCF | 260.01 |
Financial Position
The company has a current ratio of 6.30, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.30 |
| Quick Ratio | 5.73 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.37 |
| Interest Coverage | 1,985.16 |
Financial Efficiency
Return on equity (ROE) is 8.07% and return on invested capital (ROIC) is 13.21%.
| Return on Equity (ROE) | 8.07% |
| Return on Assets (ROA) | 4.52% |
| Return on Invested Capital (ROIC) | 13.21% |
| Return on Capital Employed (ROCE) | 7.98% |
| Weighted Average Cost of Capital (WACC) | 6.16% |
| Revenue Per Employee | 643,410 |
| Profits Per Employee | 118,733 |
| Employee Count | 1,042 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 7.10 |
Taxes
In the past 12 months, SHE:301277 has paid 17.72 million in taxes.
| Income Tax | 17.72M |
| Effective Tax Rate | 12.64% |
Stock Price Statistics
The stock price has increased by +27.99% in the last 52 weeks. The beta is 0.35, so SHE:301277's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +27.99% |
| 50-Day Moving Average | 12.30 |
| 200-Day Moving Average | 13.57 |
| Relative Strength Index (RSI) | 55.56 |
| Average Volume (20 Days) | 3,704,478 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301277 had revenue of CNY 670.43 million and earned 123.72 million in profits. Earnings per share was 0.32.
| Revenue | 670.43M |
| Gross Profit | 241.23M |
| Operating Income | 126.05M |
| Pretax Income | 140.12M |
| Net Income | 123.72M |
| EBITDA | 165.82M |
| EBIT | 126.05M |
| Earnings Per Share (EPS) | 0.32 |
Balance Sheet
The company has 715.80 million in cash and 6.09 million in debt, with a net cash position of 709.71 million or 1.81 per share.
| Cash & Cash Equivalents | 715.80M |
| Total Debt | 6.09M |
| Net Cash | 709.71M |
| Net Cash Per Share | 1.81 |
| Equity (Book Value) | 1.52B |
| Book Value Per Share | 3.88 |
| Working Capital | 870.69M |
Cash Flow
In the last 12 months, operating cash flow was 135.19 million and capital expenditures -118.69 million, giving a free cash flow of 16.50 million.
| Operating Cash Flow | 135.19M |
| Capital Expenditures | -118.69M |
| Free Cash Flow | 16.50M |
| FCF Per Share | 0.04 |
Margins
Gross margin is 35.98%, with operating and profit margins of 18.80% and 18.45%.
| Gross Margin | 35.98% |
| Operating Margin | 18.80% |
| Pretax Margin | 20.90% |
| Profit Margin | 18.45% |
| EBITDA Margin | 24.73% |
| EBIT Margin | 18.80% |
| FCF Margin | 2.46% |
Dividends & Yields
This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 2.24%.
| Dividend Per Share | 0.29 |
| Dividend Yield | 2.24% |
| Dividend Growth (YoY) | 40.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 90.55% |
| Buyback Yield | -0.39% |
| Shareholder Yield | 1.89% |
| Earnings Yield | 2.47% |
| FCF Yield | 0.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 16, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | Apr 16, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
SHE:301277 has an Altman Z-Score of 14.86 and a Piotroski F-Score of 4.
| Altman Z-Score | 14.86 |
| Piotroski F-Score | 4 |